Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2015-02-25
Product name
Brava Skin Barrier Wipe
CAS No.
107-46-0
1.2.1 Relevant identified uses
Medical device Class I A skin barrier wipe which provides a thin protec- tive layer on the skin
Manufacturer Name
Coloplast A/S
Emergency telephone
(DK) +45 82 12 12 12
Icons in SDS
Company Information
company name
Coloplast A/S
e-mail address of the competent person responsible for the Safety Data Sheet
msds@coloplast.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H400
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008 This product is regulated as a medical device in European Economic Area (EEA). In other regions it may be regulated as a medical device, a cosmetic or not regulated. The product is assessed and supplied with a safety data sheet in accordance with Regulation (EC) no 1272/2008. Labelling of the Brava® Skin Barrier Wipe product is prepared in accordance with Directive 93/42/EEC on medical de- vices and local legislation.
EU Classification
Regulation (EC) No 1272/2008: Flam. Liq. 2;H225 Aquatic Acute 1;H400 Wording of H-statements – see section 16.
2.2 Label elements
The product is a medical device in EAA and therefore the labelling elements from the CLP regulations do not apply, according to Regulation (EC) No 1272/2008, Title I, Article 1, Section 5. The below illustrated pictograms, signal words and hazard statements are therefore only listed in the present MSDS and not necessarily present on the product labelling.
Signal word
Danger
Hazard statements
H225: Highly flammable liquid and vapour. H400: Very toxic to aquatic life.
Precautionary statements
P210: Keep away from heat/sparks/open flames/hot surfaces. - No smoking. P233: Hold beholderen tæt lukket. P243: Take precautionary measures against static discharge. P273: Avoid release to the environment.
2.3 Other hazards
None PBT/vPvB: No ingredients are PBT/vPvB, according to the criteria in REACH Annex XIII.
